Drug Trial Radar · NCT06018428
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
Last checked: Nov 19, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Sep 12, 2023
Primary completion
Jun 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Q32 Bio Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 30, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. Part B is a multicenter, open-label study to assess the efficacy, safety, and tolerability of bempikibart (ADX-914) in participants with severe Alopecia Areata.
Conditions
- Alopecia Areata
Interventions
bempikibart (ADX-914)Drug
Subcutaneous administration of bempikibart (ADX-914)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Mean relative percent change in SALT scoreTime frame: 24 Weeks
- Part B: Mean percent change from baseline in SALT scoreTime frame: 36 weeks
Locations
33 sites in 2 countries. Site status is shown where the registry gives one.
Scottsdale, Arizona
Scottsdale, Arizona
Fayetteville, Arkansas
Fayetteville, Arkansas
Hot Springs, Arkansas
Hot Springs, Arkansas
Encinitas, California
Encinitas, California
Fountain Valley, California
Fountain Valley, California
Lomita, California
Lomita, California
New Haven, Connecticut
New Haven, Connecticut
Miami, Florida
Miami, Florida
Tampa, Florida
Tampa, Florida
Clarksville, Indiana
Clarksville, Indiana
Bowling Green, Kentucky
Bowling Green, Kentucky
Burlington, Massachusetts
Burlington, Massachusetts
Troy, Michigan
Troy, Michigan
Warren, Michigan
Warren, Michigan
New York, New York
New York, New York
New York, New York
New York, New York
Wilmington, North Carolina
Wilmington, North Carolina
Bexley, Ohio
Bexley, Ohio
Clinical Trials
Canton, Ohio
Mason, Ohio
Mason, Ohio
Mayfield Heights, Ohio
Mayfield Heights, Ohio
Portland, Oregon
Portland, Oregon
Austin, Texas
Austin, Texas
Frisco, Texas
Frisco, Texas
Houston, Texas
Houston, Texas
San Antonio, Texas
San Antonio, Texas
Jordan, Utah
Jordan, Utah
Spokane, Washington
Spokane, Washington
Clinical Trials
Calgary, Alberta, Canada
Clinical Trials
Winnipeg, Manitoba, Canada
Clinical Trials
Oakville, Ontario, Canada
Clinical Trials
Peterborough, Ontario, Canada
Clinical Trials
Waterloo, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.